Updates to Cancer Survivorship: Optimizing Care and Outcomes
- Continuing Education
Start Today Register and begin immediately.
Deliver cutting-edge, evidence-based strategies to help clinicians recognize, manage, and coordinate the complex medical and psychosocial needs of cancer survivors across the continuum of care.
- Online; Self-Paced
This course is offered on demand and participants progress through the materials at their own pace.
Continuing Education Credits
Earn up to:
20.50 AMA PRA Category 1 Credit(s) ™
0.50 Risk Management Credits
View All
On This Page
Overview
The goals of this program are to increase awareness among clinicians about the need for comprehensive cancer survivorship care and specific areas where improved survivorship care can lead to improved patient outcomes. This program will educate participants regarding the evolving evidence surrounding the unique medical risks and psychosocial concerns that cancer survivors face from diagnosis through long-term survivorship. The participants will learn to recognize evidence-based screening, prevention and management strategies for potential long-term, late effects and how to tailor these for patients at varying risks for problems. This course will also introduce, highlight and encourage the participant to utilize the emerging body of guidelines, tools, and resources that are available to optimize the coordination and delivery of survivorship care. We have added several modules to this second version of our course to address specific groups and types of survivors that were not covered extensively in the first course.
Learning Objectives
- Describe the trends in cancer survivorship and the role of providers after initial cancer treatment.
- Identify the medical and psychosocial needs of diverse cancer survivors, and develop strategies to address those needs.
- Review updated evidence and tools to enhance the delivery and coordination of care for cancer survivors.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Dana-Farber Cancer Institute.
Participant Types
Primary Care Physicians, Physician Assistants, Nurses, Nurse Practitioners, Specialty Physicians, Psychologists, and Social Workers.
Schedule
All agenda sessions are in Eastern Time.
Outline
Topic: Introduction and Major Cancer Types - Module 1
Topic 1: Introduction/Survivorship 101
Ann Partridge
Topic 2: Evidence-based Approaches to Breast Cancer Survivorship Care
Rachel Freedman
Topic 3: Colorectal Cancer Survivorship Care
Leah Biller
Topic 4: Caring for Survivors of Genitourinary Cancers: Approaches for a Heterogeneous Disease Group
Alicia Morgans
Topic 5: Survivorship in the Hematologic Malignancies
Ann S. LaCasce
Topic 6: Unique Concerns of Head & Neck Cancer Survivors
Danielle Margalit
Topic 7: Survivorship Care for the BMT Patient
Abigail Ciampa
Topic 8: Evidence-Based Approaches to Survivorship Care for Patients with Gynecologic Cancers
Alexi Wright
Topic 9: Lung Cancer Survivorship
Mark Awad
Topic 10: Approaches to Caring for Adult Survivors of Childhood Cancers
Lynda Vrooman
Topic 11: Adolescent and Young Adults Cancer Survivorship
David Shulman
Topic: Physical Late and Long-term Effects of Cancer - Module 2
Topic 12: Onco-Cardiology in Cancer Patients and Survivors
Anju Nohria
Topic 13: Onco-Endocrinology in Cancer Patients and Survivors
Ole-Petter Hamnvik
Topic 14: Onconephrology: Cancer and Kidney Disease
Raad Chowdhury
Topic 15: Oncofertility: At Diagnosis and Beyond
Phil Poorvu
Topic 16: Approaches to Pain Management in Cancer Survivors
Laura Petrillo
Topic 17: Survivorship Care - Immunotherapy
Alok Tewari
Topic: Psychosocial Health After Cancer - Module 3
Topic 18: Sexual Health after Cancer
Sharon Bober
Topic 19: Tackling Insomnia in Survivors
Eric Zhou
Topic 20: Management of Psychosocial Concerns after Cancer & the New Normal with your Loved Ones and Life
Cristina Pozo-Kaderman
Topic: Survivorship Healthy Living and Special Care Considerations - Module 4
Topic 21: Integrating Cancer Survivorship into Primary Care...and Vice Versa
Larissa Nekhlyudov
Topic: Case Interview
Larissa Nekhlyudov; Elizabeth Savol
Topic 22: Lifestyle Interventions for Cancer Survivors: Why and How?
Jennifer Ligibel
Topic 23: Cultural Disparities/Survivorship Diversity: Culturally Sensitive Survivorship Care
Narjust Florez
Topic 24: Survivorship Care for Older Cancer Patients
Tammy Hshieh
Topic 25: Genetics and Survivorship Care
Huma Rana
Topic 26: Conclusion: Frequently Asked Questions and Resources for Cancer Survivorship
Alicia Morgans; Larissa Nekhlyudov
Posttest and Evaluation
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Larissa Nekhlyudov, MD, MPH
Course Director
- Clinical Director, Internal Medicine, David B. Perini Jr. Quality of Life Clinic, Dana-Farber Cancer Institute
- Professor of Medicine, Harvard Medical School
Alicia Morgans, MD, MPH
Course Director
- Director, Survivorship Program
- Physician, Dana-Farber Cancer Institute
- Associate Professor of Medicine, Harvard Medical School
Mark Awad, MD, PhD
Chief, Thoracic Oncology Service, Memorial Sloan Kettering
Associate Professor, Weill Cornell Medicine
Leah Biller, MD
Physician, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Sharon Bober, PhD
Founder and Director, Sexual Health Program & Institute Psychologist, Dana-Farber Cancer Institute
Associate Professor of Psychology, Harvard Medical School
Raad B. Chowdhury, MD
Associate Physician, Onconephrology, Brigham and Women's Hospital
Instructor in Medicine, Harvard Medical School
Abigail Slate Ciampa, MSN, APRN-BC
Nurse Practitioner, Adult Survivorship Program, Dana-Farber Cancer Institute
Narjust Florez, MD
Associate Director, Cancer Care Equity Program and Physician, Dana-Farber Cancer Institute
Member of the Faculty, Harvard Medical School
Rachel A. Freedman, MD, MPH
Medical Director, DFCI Collaborative and Strategic Alliances and Senior Physician, Dana-Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School
Ole-Petter Hamnvik, MBBCh, BAO, MM
Program Director, Endocrinology Fellowship, Brigham and Women's Hospital
Associate Professor of Medicine, Harvard Medical School
Tammy Hshieh, MD, MPH
Associate Physician, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Ann S. LaCasce, MD, MMSc
Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology, Fellowship Program in Hematology/Oncology Chair and Institute Physician, Dana-Farber Cacner Institute
Associate Professor of Medicine, Harvard Medical School
Jennifer Ligibel, MD
Director, Leonard P. Zakim Center for Integrative Therapies and Healthy Living, Director, Center for Faculty Well-Being and Senior Physician, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Danielle N. Margalit, MD, MPH
Director of Radiation Oncology, Merkel Cell Cancer Center and Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Radiation Oncology, Harvard Medical School
Anju Nohria, MD
Director, Cardio-Oncology Program, Dana-Farber Brigham Cancer Center
Associate Professor, Harvard Medical School
Ann H. Partridge, MD, MPH
Interim chair of the Department of Medical Oncology, Eric P. Winer, MD, Chair in Breast Cancer Research, and Senior Physician, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Laura Petrillo, MD
Palliative care physician-investigator, Division of Palliative Care and Geriatrics, Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School
Philip D. Poorvu, MD
Senior Physician, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Cristina Pozo-Kaderman, PhD
Senior Psychologist, Director of Young Adult Program and Director of Interprofessional Education, Dana-Farber Cancer Institute
Huma Q. Rana, MD, MPH
Clinical Director, Cancer Genetics and Prevention and Senior Physician, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
David Shulman, MD
Physician, Dana-Farber Cancer Institute
Assistant Professor of Pediatrics, Harvard Medical School
Alok Tewari, MD, PhD
Physician, Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School
Lynda Vrooman, MD, MMSc
Clinical Program Leader, Pediatric Survivorship Program, Medical Director, David B. Perini, Jr. Quality of Life Clinic and Senior Physician, Dana-Farber Cancer Institute
Assistant Professor of Pediatrics, Harvard Medical School
Alexi Wright, MD, MPH
Director, Gynecologic Oncology Outcomes Research and Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Eric Zhou, PhD
Assistant Professor, Harvard Medical School
Gift/Sponsor
Special Garil Family Acknowledgement
Educational Gift
We wish to recognize and thank the Garil family (Bernie and Ethel and their son, Michael) for their contributions to the field of survivorship and late effects research/education. We are immensely grateful for their generous support of this continuing medical education course on cancer survivorship.
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Fee Disclaimer
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment.
At the end of the registration process, a $5 non-refundable processing fee will be added to your registration. Because online course materials can be accessed immediately, refunds are not permitted.
| Role | Standard Price |
|---|---|
| Physician (MD/DO) | $375.00 |
| Nurse (RN/APRN) | $275.00 |
| Resident/Fellow | $275.00 |
| Allied Health Professional / Other | $275.00 |
Accreditation
The Harvard Medical School designates this enduring material for a maximum of 20.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 0.50 credits of Risk Management Study. This includes 0.50 credits of Opioid Education and Pain Management Training. Please check your individual state licensing board requirements before claiming these credits.
For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.